JBF Capital’s Biogen BIIB Stock Holding History

JBF Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-10,000	Closed	-$3.15M	–	61
2014 Q2	$3.15M	Buy	10,000 +7,500	+300%	+$2.26M	0.46%	14
2014 Q1	$765K	Hold	2,500	–	–	0.12%	41
2013 Q4	$699K	Buy	+2,500	New	+$647K	0.11%	55

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JBF Capital's BIIB Position: Q3 2014 in Review

JBF Capital sold out of Biogen (BIIB) in Q3 2014, closing a stake of 10,000 shares — an estimated $3.15M sold.

JBF Capital first reported a position in BIIB in Q4 2013 and held it in 3 quarters. The position peaked at $3.15M in Q2 2014. 819 funds tracked by Wall St. Rank hold BIIB as of Q3 2014.

JBF Capital reported no remaining Biogen position as of Q3 2014 after selling out during the quarter.
JBF Capital sold 10,000 Biogen shares in Q3 2014, an estimated $3.15M.
JBF Capital first reported a position in Biogen in Q4 2013 and held it in 3 quarters.
JBF Capital's Biogen position peaked at $3.15M in Q2 2014.
819 funds tracked by Wall St. Rank held Biogen as of Q3 2014.

Based on JBF Capital's 13F filing for Q3 2014, filed 16 Oct 2014.